유종한

교수
  #유방암#유방암수술#유방악성질환

학력

2016.02 서울대학교 대학원 의학 박사 졸업
2008.08 서울대학교 대학원 의학 석사 졸업
2000.02 서울대학교 의학과 졸업

경력

2018.0301 ~현재 삼성서울병원 외과 전임대우 부교수
2017.0301 ~현재 삼성서울병원 유방암센터 간사
2015.10 ~ 2018.02 삼성서울병원 외과 진료부교수
2015.03 ~ 2015.09 서울아산병원 외과 임상부교수
2010.03 ~ 2015.02 서울아산병원 외과 임상조교수
2009.03 ~ 2010.02 서울대학교병원 외과 진료교수
2008.05 ~ 2009.02 서울대학교병원 외과 전임의
2001.03 ~ 2005.02 서울대학교병원 외과 레지던트 과정 수료
2000.03 ~ 2001.02 서울대학교병원 인턴과정 수료

논문

J CLIN MED 2020 10.3390/jcm9041192
Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence
Ryu1, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK

JPN J CLIN ONCOL 2020 10.1093/jjco/hyz147
Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors
Ryu1, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J

CANCER 2020 10.1002/cncr.32693
Breast cancer screening disparities between women with and without disabilities: A national database study in South Korea
Shin1, DW; Yu, J; Cho, J; Lee, SK; Jung, JH; Han, K; Kim, SY; Yoo, JE; Yeob, KE; Kim, YY; Park, JH; Park, JH; Kawachi, I

J BREAST CANC 2019 10.4048/jbc.2019.22.e48
Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm
Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE

BREAST CANCER RES TR 2019 10.1007/s10549-019-05214-y
Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy
Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK

CANCER RES TREAT 2019 10.4143/crt.2018.342
Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance
Kim1, HK; Park, KH; Kim, Y; Park, SE; Lee, HS; Lim, SW; Cho, JH; Kim, JY; Lee, JE; Ahn, JS; Im, YH; Yu, JH; Park, YH

ANN SURG TREAT RES 2019 10.4174/astr.2019.96.4.169
Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer
Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK

PLoS One 2019 10.1371/journal.pone.0212309
Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment
Kwon1, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

EJSO-EUR J SURG ONC 2019 10.1016/j.ejso.2018.09.011
A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning
Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

ONCOL REP 2019 10.3892/or.2018.6910
TP53 upregulates -smooth muscle actin expression in tamoxifen-resistant breast cancer cells
Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE

BMC CANCER 2019 10.1186/s12885-018-5258-9
Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea
Kim1, HK; Lee, SH; Kim, YJ; Park, SE; Lee, HS; Lim, SW; Cho, JH; Kim, JY; Ahn, JS; Im, YH; Yu, JH; Park, YH

BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
Hwang1, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY

BREAST CANCER RES TR 2019 10.1007/s10549-018-4947-z
Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?
Lee1, SK; Kim, SW; Yu, JH; Lee, JE; Kim, JY; Woo, J; Lee, S; Kim, EK; Moon, HG; Ko, SS; Nam, SJ

BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea
Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW

NUTRIENTS 2019 10.3390/nu11010037
Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients
Choi1, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY

ASIAN J SURG 2019 10.1016/j.asjsur.2018.06.004
Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice
Lee1, SB; Yu, JH; Park, H; Kim, HJ; Park, SH; Chae, BJ; Youn, HJ; Jung, SY; Kim, EK; Jung, YS; Son, BH

HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3
The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans
Kim1, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY

KAOHSIUNG J MED SCI 2018 10.1016/j.kjms.2018.07.003
Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer
Bae1, SY; Jung, SP; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ

BREAST CANCER RES TR 2018 10.1007/s10549-018-4948-y
Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer
Ryu1, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW

J BREAST CANC 2018 10.4048/jbc.2018.21.e50
Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study
Choi1, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW

J BREAST CANC 2018 10.4048/jbc.2018.21.e54
Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis
Choi1, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

PHYTOMEDICINE 2018 10.1016/j.phymed.2018.08.004
Berberine down-regulates IL-8 expression through inhibition of the EGFR/ MEK/ERK pathway in triple-negative breast cancer cells
Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE

CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.010
Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment
Cho1, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S

BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort
Kim1, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

ONCOLOGY-BASEL 2018 10.1159/000488944
Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype
Bae1, SY; Jung, SP; Jung, ES; Park, SM; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ

HEALTH QUAL LIFE OUT 2018 10.1186/s12955-018-0965-0
Uneven recovery patterns of compromised health-related quality of life (EQ-5D-3 L) domains for breast Cancer survivors: a comparative study
Yu1, J; Son, WS; Lee, SB; Chung, IY; Son, BH; Ahn, SH; Jo, MW; Lee, JW

J BREAST CANC 2018 10.4048/jbc.2018.21.2.173
Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer
Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

J BREAST CANC 2018 10.4048/jbc.2018.21.2.206
Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy?
Cho1, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY

J BREAST CANC 2018 10.4048/jbc.2018.21.2.222
Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer
Kim1, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

WORLD J SURG 2018 10.1007/s00268-017-4342-7
Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer
Park1, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ

J BREAST CANC 2018 10.4048/jbc.2018.21.1.21
Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells
Jeong1, Y; You, D; Kang, HG; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Kim, S

J BREAST CANC 2018 10.4048/jbc.2018.21.1.91
Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy
Park1, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH

CLIN BREAST CANCER 2018 10.1016/j.clbc.2017.06.003
Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane
Park1, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ

CELL PHYSIOL BIOCHEM 2018 10.1159/000487171
Berberine Suppresses Cell Motility Through Downregulation of TGF-beta 1 in Triple Negative Breast Cancer Cells
Kim1, S; Lee, J; You, D; Jeong, Y; Jeon, M; Yu, J; Kim, SW; Nam, SJ; Lee, JE

TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.002
Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast
Kim1, JY; Yu, JH; Nam, SJ; Kim, SW; Lee, SK; Park, WY; Noh, DY; Nam, DH; Park, YH; Han, W; Lee, JE

BREAST CANCER RES TR 2017 10.1007/s10549-017-4472-5
Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society
Ryu1, JM; Yu, J; Kim, SI; Kim, KS; Moon, HG; Choi, JE; Jeong, J; Byun, KD; Nam, SJ; Lee, JE; Lee, SK; Kim, SW

ONCOTARGET 2017 10.18632/oncotarget.22220
Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer
Woo1, HI; Lee, SK; Kim, J; Kim, SW; Yu, J; Bae, SY; Lee, JE; Nam, SJ; Lee, SY

ONCOTARGET 2017 10.18632/oncotarget.22193
Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers
Park1, B; Hopper, JL; Win, AK; Dowty, JG; Sung, HK; Ahn, C; Kim, SW; Lee, MH; Lee, J; Lee, JW; Kang, E; Yu, JH; Kim, KS; Moon, BI; Han, W; Noh, DY; Park, SK

CLIN BREAST CANCER 2017 10.1016/j.clbc.2017.03.014
Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis
Ryu1, JM; Lee, SK; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Han, SH; Jung, YS; Nam, SJ

BREAST CANCER RES TR 2017 10.1007/s10549-017-4398-y
Radiation-related heart disease after breast cancer radiation therapy in Korean women
Chang1, JS; Ko, BK; Bae, JW; Yu, JH; Park, MH; Jung, Y; Jeon, YW; Kim, KH; Shin, J; Suh, CO; Kim, YB

CANCER RES TREAT 2017 10.4143/crt.2016.528
Education Level Is a Strong Prognosticator in the Subgroup Aged More Than 50 Years Regardless of the Molecular Subtype of Breast Cancer: A Study Based on the Nationwide Korean Breast Cancer Registry Database
Hwang1, KT; Noh, W; Cho, SH; Yu, J; Park, MH; Jeong, J; Lee, HJ; Kim, J; Oh, S; Kim, YA

J BREAST CANC 2017 10.4048/jbc.2017.203.270
Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy
Kim1, I; Ryu, JM; Kim, JM; Choi, HJ; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ

J BREAST CANC 2017 10.4048/jbc.2017.20.3.297
Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry
You1, K; Park, S; Ryu, JM; Kim, I; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE

J Breast Cancer. 2017 Mar;20(1):74-81. doi: 10.4048/jbc.2017.20.1.74. Epub 2017 Mar 24.
Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study
Ryu JM11, Paik HJ1, Park S1, Yi HW1, Nam SJ1, Kim SW1, Lee SK1, Yu J1, Bae SY1, Lee JE1.

J Breast Cancer. 2017 Mar;20(1):91-97. doi: 10.4048/jbc.2017.20.1.91. Epub 2017 Mar 24.
Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy
Kim I11, Ryu JM1, Paik HJ1, Park S1, Bae SY1, Lee SK1, Yu J1, Kim SW1, Nam SJ1, Lee JE1.

Medicine (Baltimore). 2017 Jan;96(1):e5746. doi: 10.1097/MD.0000000000005746.
Conditional disease-free survival among patients with breast cancer
Paik HJ11, Lee SK, Ryu JM, Park S, Kim I, Bae SY, Yu J, Lee JE, Kim SW, Nam SJ.

Breast. 2016 Dec;30:111-117. doi: 10.1016/j.breast.2016.08.011. Epub 2016 Sep 30.
Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype
Alramadhan M11, Ryu JM1, Rayzah M1, Nam SJ1, Kim SW1, Yu J1, Lee SK1, Bae SY1, Park S1, Paik HJ1, Lee JE2.

Breast Cancer Res Treat. 2016 Oct;159(3):489-98. doi: 10.1007/s10549-016-3943-4. Epub 2016 Sep 2.
Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society
Ryu JM11, Lee HJ2, Yoon TI3, Lee ES4, Lee SJ5, Jung JH6, Chae BJ7, Nam SJ1, Lee JE1, Lee SK1, Bae SY1, Yu J1, Kim SW8; Korean Breast Cancer Society Consortium.

저서

저서 내용이 없습니다.

보도자료

"장애인 유방암 검진, 형평성 제고 방안 필요
"http://medipana.com/news/news_viewer.asp?NewsNum=259167&MainKind=A&NewsKind=5&vCount=12&vKind=1

장애인 유방암 검진율 '절반' 불과…"비장애인과 격차 커져"
https://www.yna.co.kr/view/AKR20200629058200017?input=1195m

포스팅

포스팅 내용이 없습니다.

영상자료

'유전자'로 암 진단하고 맞춤형 치료…암 없는 미래 오나
https://imnews.imbc.com/replay/2017/nwdesk/article/4349504_30212.html

발표자료

발표자료 내용이 없습니다.